EPIEN MEDICAL, INC.

SAINT PAUL, MN · CIK 0001881672 · Medtech · Private

Chemical desiccation debridement device for oral mucosal and submucosal tissue restoration

epien.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$900K
1 Form D · Sep 2021
61 months since last filing
Contracts
—
No federal contracts on record
Patents
8
1 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$900,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1106FORCYTE BIOTECHNOLOGIES, INC.—$1.0M
1107Multiply Labs—$41M
1108ALPS DX LLC—$900K
1109EPIEN MEDICAL, INC.—$900K
1110OnPoint Surgical, Inc.—$200K
1111Renovo Concepts, Inc.—$3.3M
1112Prometheus Therapeutics Inc.—$1.8M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Reginald DupreDirector · Executive Officer

Patents

USPTO · 1 granted of 8
  • Wound Care And Method For Preventing Wound Infectionapplication
  • Formulation For Treating Chronic Woundsapplication
  • Formulation For Treating Chronic Woundsgranted
  • Method And Formulation For Treating Mucosal Discontinuities And For Reducing Biofilmsapplication
  • Odorless Formulation For Treating Mucosal Discontinuitiesapplication
  • Dentinal Hypersensitivity Treatmentapplication
  • Wound Care And Method For Preventing Wound Infectionapplication
  • Method And Material For Reducing Biofilmapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.